NCT01155102View on ClinicalTrials.gov

Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Breast Cancer
Interventions
DRUG

Anastrozole

1 mg tablet

Trial Locations (1)

65802

Bio-Kinetic Clinical Applications, Springfield

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT01155102 - Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions | Biotech Hunter | Biotech Hunter